Bortemib 2 Injection

By Bortemib

Rx

1 Injection in a Vial

Composition icon

Composition

Bortezomib(2mg)

Manufacturer - Khandelwal Laboratories Pvt Ltd icon

Manufacturer - Khandelwal Laboratories Pvt Ltd

KHANDELWAL LABORATORIES PVT. LTD, 79/87 D.LADPATH, MUMBAI 400 033, INDIA

Expires on or after icon

Expires on or after

July, 2025

About Bortemib 2 Injection

Introduction:

Bortemib 2 Injection is a medication used in the treatment of multiple myeloma and mantle-cell lymphoma. By halting or slowing down the growth of cancer cells, this injection plays a crucial role in combating these conditions. Administered by a skilled healthcare provider through an injection, the dosage and frequency of Bortemib 2 Injection are determined by your doctor based on your specific treatment needs. It is vital to strictly adhere to your doctor's instructions regarding the administration of this medication to prevent serious side effects that may arise from incorrect dosage or overconsumption.

Common side effects of Bortemib 2 Injection include fatigue, nausea, vomiting, and loss of appetite. It is advisable to stay well-hydrated throughout the treatment period by consuming plenty of fluids daily. Due to potential side effects such as fatigue and dizziness, it is recommended to avoid driving or operating heavy machinery while using this medication. Furthermore, this injection can lead to a reduction in blood cell counts, making you more susceptible to infections. Regular blood tests are essential to monitor blood cell levels, as well as the health of your heart, liver, and blood uric acid levels.

Individuals with liver, kidney, heart disease, or bleeding issues should consult their doctor before initiating treatment with Bortemib 2 Injection. Additionally, it is crucial to seek medical advice if you experience symptoms like memory loss or cognitive difficulties while on this medication. Inform your healthcare team about all medications you are currently using, as there may be interactions with other drugs. Pregnant individuals or those breastfeeding should avoid the use of this medication, and it is recommended that both males and females utilize effective contraception during treatment to prevent pregnancy.


Benefits

Bortemib 2 Injection offers several benefits for individuals battling Multiple Myeloma and Mantle-cell lymphoma. In the case of Multiple Myeloma, this medication plays a crucial role in your treatment journey by working alongside other cancer therapies like chemotherapy. By targeting and eliminating cancerous cells, Bortemib 2 Injection helps to prevent their further growth and spread throughout the body. This not only aids in halting the progression of the disease but also increases the chances of survival for people with Multiple Myeloma. To maximize the benefits of this treatment, it is essential to follow your doctor's instructions diligently. Additionally, the prescription of calcium and Vitamin D3 supplements can further support the treatment process, particularly if you have low blood calcium levels.


For individuals with Mantle-cell lymphoma, Bortemib 2 Injection serves as an effective tool in combating this type of non-Hodgkin's lymphoma. By inhibiting cancer growth and interfering with the actions of chemicals necessary for its progression, this medication helps to contain the disease and prevent its spread. To complement the treatment, it is important to take precautions such as avoiding crowded places, practicing frequent hand washing to prevent infections, and staying hydrated unless advised otherwise by your healthcare provider.


Overall, the active ingredient in Bortemib 2 Injection, bortezomib, functions as a proteasome inhibitor that targets the mechanisms involved in cancer cell growth. Whether used alone or in combination with other medications, Bortemib 2 Injection proves to be a valuable asset in the fight against Multiple Myeloma and Mantle-cell lymphoma for patients aged 18 years and older. By disrupting the function of proteasomes and selectively killing cancer cells, this medication offers hope and improved outcomes for individuals grappling with these challenging conditions.


How to use the Bortemib 2 Injection

To use Bortemib 2 Injection, it is important to note that only a qualified healthcare professional, such as your doctor or nurse, should administer this medicine. Please do not try to administer it yourself. This injection will be given to you by a healthcare provider who is trained to properly handle and administer the medication. It is crucial to follow your healthcare provider's instructions carefully regarding the dosage and frequency of the injections. If you have any questions or concerns about how to use Bortemib 2 Injection, do not hesitate to ask your healthcare provider for guidance. They are there to ensure that you receive the medication safely and effectively. Remember, always seek medical advice and assistance when it comes to using this injection to ensure your well-being and proper treatment.


Uses of Bortemib 2 Injection

"Bortemib 2 Injection" is commonly used in the treatment of two specific types of cancers - Multiple myeloma and Mantle-cell lymphoma. This medication is used to target and treat these conditions effectively. Multiple myeloma is a form of cancer that affects the plasma cells in the bone marrow, while Mantle-cell lymphoma is a type of non-Hodgkin lymphoma that affects the lymph nodes and other tissues. The use of Bortemib 2 Injection in these conditions helps to combat the cancer cells and slow down their growth, providing necessary relief to patients suffering from these diseases.


What conditions Bortemib 2 Injection treats?

'Bortemib 2 Injection' is indicated for the treatment of multiple myeloma and mantle cell lymphoma, which are types of cancers affecting the bone marrow and lymphatic system. In multiple myeloma, cancer cells grow in various parts of the body, such as the spine, skull, pelvis, and ribs. Mantle cell lymphoma is a rare form of non-Hodgkin lymphoma that develops from abnormal B-cells. These conditions involve uncontrolled growth and spread of cancerous cells, which can harm healthy tissues and organs.


Should you consult a doctor?

If you experience any concerning symptoms while taking Bortemib 2 Injection, it is crucial to seek medical help promptly. Contact your doctor if you develop symptoms such as memory loss, trouble in thinking, or persistent side effects like fatigue, nausea, vomiting, or loss of appetite. Additionally, if you notice unusual symptoms like low blood platelets, peripheral neuropathy (tingling and numbness in feet and hands), psychiatric disturbances, fever, anemia, diarrhea, decreased white blood cell count, or constipation, do not hesitate to consult your healthcare provider. Regular monitoring through blood tests is required to check your blood cell levels and overall health status. Inform your doctor about any other medications you are taking as they may interact with Bortemib 2 Injection. It is essential to seek medical advice if you have underlying liver, kidney, heart issues, or bleeding problems before starting this treatment. If you are pregnant, planning to become pregnant, or breastfeeding, discuss with your doctor about the potential risks and use of effective contraception during treatment.


Side effects of Bortemib 2 Injection

Side effects of Bortemib 2 Injection may occur as your body adapts to the medicine. While most side effects are temporary and don't need medical attention, consult your doctor if they persist or cause concern. Common side effects include low blood platelets, fatigue, peripheral neuropathy (tingling or numbness in feet and hands), psychiatric disturbances, nausea, vomiting, loss of appetite, fever, anemia, diarrhea, decreased appetite, and decreased white blood cell count. Additionally, some individuals may experience constipation, nausea, diarrhoea, thrombocytopenia (low blood platelet count), neutropenia (low neutrophil count), peripheral neuropathy, fatigue, neuralgia (head or face pain), muscle and bone pain, anemia, leukopenia (low white blood cell count), high blood pressure, dehydration, vomiting, loss of appetite, lymphopenia (low lymphocyte count), rash, raised body temperature, anorexia, and various infections such as pneumonia, respiratory infections, bronchitis, fungal infections, and flu-like illness.


Safety advice

scroll

liver

Bortemib 2 Injection needs to be approached carefully for patients with liver disease. It may be necessary to adjust the dosage of the injection in such cases. It is important to consult with your doctor regarding the use of Bortemib 2 Injection if you have liver issues.

scroll

kidney

Bortemib 2 Injection should be used carefully in patients with severe kidney disease. Dose adjustment may be necessary, so consult your doctor. Limited information is available for using Bortemib 2 Injection in these patients.

scroll

alcohol

It is advised to avoid alcohol consumption while taking Bortemib 2 Injection as it can lead to increased drowsiness.

scroll

driving

Bortemib 2 Injection may cause tiredness, dizziness, fainting, or blurred vision which can affect your ability to drive. Be cautious while driving as these side effects may impair focus and reaction time.

scroll

pregnancy

Bortemib 2 Injection should not be used during pregnancy due to potential risk to the developing baby. In rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor.

scroll

breastfeeding

Bortemib 2 Injection is not recommended during breastfeeding as it may harm the baby due to potential toxicity.


Consumption warning before consuming Bortemib 2 Injection

Before consuming Bortemib 2 Injection, it is important to follow your doctor's prescribed dosage without stopping midway. Inform your doctor about any allergies or existing conditions such as peripheral neuropathy, hypotension, cardiac, lung, or gastrointestinal disorders, as well as thrombocytopenia, neutropenia, or hepatic disorders. It is crucial to mention if you have diabetes, as this medicine can impact your blood glucose levels, requiring close monitoring and potential adjustments to your diabetes medication. Pregnant individuals should avoid Bortemib 2 Injection due to potential harm to the unborn baby. Both men and women using this injection should use birth control during treatment and for at least six months after. Breastfeeding should be avoided during treatment and for four months after the last dose. Consult your healthcare provider for further guidance and monitoring while on Bortemib 2 Injection.


Disease interactions

When considering the use of Bortemib 2 Injection, it is crucial to inform your doctor about any existing conditions you may have. Special care and close monitoring are necessary if you have peripheral neuropathy, which is a malfunction of the nerves, hypotension (low blood pressure), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur during cancer treatment), or hepatic disorders. It is important to address these conditions before proceeding with the use of Bortemib 2 Injection to ensure your safety and well-being.


What if you forgot to take Bortemib 2 Injection?

If you happen to miss a dose of Bortemib 2 Injection, it is important to consult your doctor promptly for guidance. It is crucial to follow your doctor's instructions closely when it comes to your medication schedule to ensure the best outcomes for your treatment. By seeking advice from your healthcare provider, you can address the missed dose appropriately and make any necessary adjustments to your dosing regimen. Your doctor will be able to provide you with specific instructions on how to proceed in such situations, taking into account your individual circumstances and treatment plan. Your health and well-being are of utmost importance, so do not hesitate to reach out to your healthcare professional for assistance in case of a missed dose of Bortemib 2 Injection.


Related lab tests

When taking Bortemib 2 Injection, it is important to monitor certain lab tests to ensure the treatment is effective and safe for you. These lab tests include Albumin/Globulin Ratio in the serum, which helps to assess the protein levels in your blood. Monitoring your calcium levels is also crucial to maintain proper bone health and nerve function.


A Complete Blood Count (CBC) is recommended to track your overall blood health, including red blood cells, white blood cells, and platelets. Additionally, monitoring Cyclin D1 levels can help in detecting certain types of cancers such as mantle cell lymphoma. Kidney Function Tests are essential to assess how well your kidneys are working and if there are any signs of kidney damage.


Regular monitoring of these related lab tests can provide valuable information to your healthcare provider regarding the effects of Bortemib 2 Injection on your body.


Additional Information

Habit FormingNo
Chemical ClassPhenylalanine Derivative
Therapeutic Class-
Action ClassProteasome inhibitor

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

2288

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024